XomeXBio: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
XomeXBio
Largest movements
- Intangible fixed assets +€1.2m
up €1.2m (+125%), from €966,233 to €2.2m
- Receivables within one year +€748,070
up €748,070 (+153%), from €489,777 to €1.2m
of which Other amounts receivable: +€788,900
- Cash +€53,996
up €53,996 (+193%), from €27,984 to €81,980
mainly Contributions, distributions and other (+€1.5m) and Debts after one year (+€1.2m)
- Debts after one year +€1.2m
up €1.2m (+122%), from €1.0m to €2.2m
- Profit (loss) carried forward +€472,144
up €472,144 (+78.5%), from -€601,643 to -€129,499
- Investment grants +€317,284
up €317,284 (+55.7%), from €569,358 to €886,642
- Contributions +€198,934
up €198,934 (+199%), from €100,000 to €298,934
- Trade debts -€125,774
down €125,774 (-38.8%), from €324,441 to €198,667
- Depreciation +€236,456
up €236,456 (+97.2%), from €243,276 to €479,732
- Gross operating margin +€152,186
up €152,186, from -€48,756 to €103,430
- Financial income +€105,325
up €105,325 (+74.0%), from €142,340 to €247,665
- Staff costs -€45,834
down €45,834 (-11.6%), from €396,653 to €350,819
- Other operating charges +€2,790
up €2,790 (+151%), from €1,847 to €4,637
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,522,667 | €3,499,557 | +€2.0m | +130% |
| Fixed assets | 21/28 | €1,004,906 | €2,179,665 | +€1.2m | +117% |
| Intangible fixed assets | 21 | €966,233 | €2,173,531 | +€1.2m | +125% |
| Tangible fixed assets | 22/27 | €3,575 | €2,042 | -€1,533 | -42.9% |
| Furniture and vehicles | 24 | €3,575 | €2,042 | -€1,533 | -42.9% |
| Financial fixed assets | 28 | €35,098 | €4,092 | -€31,005 | -88.3% |
| Current assets | 29/58 | €517,761 | €1,319,891 | +€802,130 | +155% |
| Amounts receivable within one year | 40/41 | €489,777 | €1,237,848 | +€748,070 | +153% |
| Trade receivables | 40 | €40,830 | - | -€40,830 | |
| Other amounts receivable | 41 | €448,947 | €1,237,848 | +€788,900 | +176% |
| Cash at bank and in hand | 54/58 | €27,984 | €81,980 | +€53,996 | +193% |
| Deferred charges and accrued income | 490/1 | - | €64 | +€64 | |
| Total equity and liabilities | 10/49 | €1,522,667 | €3,499,557 | +€2.0m | +130% |
| Equity | 10/15 | €67,716 | €1,056,078 | +€988,362 | +1,460% |
| Contributions | 10/11 | €100,000 | €298,934 | +€198,934 | +199% |
| Profit (loss) carried forward | 14 | -€601,643 | -€129,499 | +€472,144 | +78.5% |
| Investment grants | 15 | €569,358 | €886,642 | +€317,284 | +55.7% |
| Amounts payable | 17/49 | €1,454,951 | €2,443,479 | +€988,528 | +67.9% |
| Amounts payable after more than one year | 17 | €1,000,754 | €2,220,935 | +€1.2m | +122% |
| Other amounts payable | 178/9 | €1,000,754 | €2,220,935 | +€1.2m | +122% |
| Amounts payable within one year | 42/48 | €454,197 | €222,544 | -€231,654 | -51.0% |
| Trade debts | 44 | €324,441 | €198,667 | -€125,774 | -38.8% |
| Suppliers | 440/4 | €324,441 | €198,667 | -€125,774 | -38.8% |
| Taxes, remuneration and social security | 45 | €129,756 | €23,876 | -€105,880 | -81.6% |
| Taxes | 450/3 | €58,584 | €799 | -€57,785 | -98.6% |
| Remuneration and social security | 454/9 | €71,172 | €23,077 | -€48,095 | -67.6% |
| Remuneration, social security and pensions | 62 | €396,653 | €350,819 | -€45,834 | -11.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €243,276 | €479,732 | +€236,456 | +97.2% |
| Other operating charges | 640/8 | €1,847 | €4,637 | +€2,790 | +151% |
| Gross operating margin | 9900 | -€48,756 | €103,430 | +€152,186 | |
| Operating profit (loss) | 9901 | -€690,533 | -€731,758 | -€41,225 | -6.0% |
| Financial income | 75/76B | €142,340 | €247,665 | +€105,325 | +74.0% |
| Recurring financial income | 75 | €142,340 | €247,665 | +€105,325 | +74.0% |
| Financial charges | 65/66B | €46,713 | €44,429 | -€2,284 | -4.9% |
| Recurring financial charges | 65 | €46,713 | €44,429 | -€2,284 | -4.9% |
| Profit (loss) for the period before taxes | 9903 | -€594,906 | -€528,522 | +€66,384 | +11.2% |
| Income taxes | 67/77 | €399 | €400 | +€1 | +0.2% |
| Profit (loss) for the period | 9904 | -€595,305 | -€528,922 | +€66,383 | +11.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€595,305 | -€528,922 | +€66,383 | +11.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.